Oxford University to test AbbVie's Humira as COVID-19 treatment

Oxford University to test AbbVie's Humira as COVID-19 treatment

Source: 
Beckers Hospital Review
snippet: 

Researchers at the University of Oxford will begin studying AbbVie's drug, Humira, as a potential treatment for COVID-19 patients, the university announced Sept. 30.